AnalystsSwayampakula RamakanthSwayampakula Ramakanth's Stock Forecasts
AnalystsSwayampakula Ramakanth
Analyst Ranking
Top 3%
#134 out of 5093 analysts
Average Return
+9.57%
Win Rate
39%222 out of 563
Risk vs Reward
Poor
Good
Swayampakula Ramakanth's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celcuity IncCELC | +685.68% | $9.29 | $72.99 | 2025-04-01 - 2025-11-04 | Buy |
Janux Therapeutics IncJANX | +645.28% | $7.09 | $52.84 | 2023-11-13 - 2024-11-12 | Buy |
Celcuity IncCELC | +582.79% | $10.69 | $72.99 | 2025-05-19 - 2025-11-04 | Buy |
Immunogen IncIMGN | +559.55% | $4.45 | $29.35 | 2023-03-02 - 2023-11-30 | Buy |
Immunogen IncIMGN | +491.73% | $4.96 | $29.35 | 2022-12-30 - 2023-11-30 | Buy |
Swayampakula Ramakanth Analyst Color
Get additional color on Swayampakula Ramakanth's coverage of popular stocks
Swayampakula Ramakanth's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Can Fite Biopharma LtdCANF | 1 | Buy | $2.50 | +509.76% | Assumes | 2 days ago |
Vor Biopharma IncVOR | 14 | Buy | $52.00 | +152.92% | Maintains | 8 days ago |
Innate Pharma SaIPHA | 16 | Buy | $5.00 | +171.74% | Upgrades | 8 days ago |
Unicycive Therapeutics IncUNCY | 2 | Buy | $22.00 | +395.50% | Maintains | 8 days ago |
Dyadic International IncDYAI | 1 | Buy | $3.00 | +185.71% | Assumes | 14 days ago |
Celcuity IncCELC | 10 | Buy | $77.00 | +5.49% | Maintains | 15 days ago |
Delcath Systems IncDCTH | 15 | Buy | $30.00 | +230.40% | Maintains | 17 days ago |
Corcept Therapeutics IncCORT | 22 | Buy | $145.00 | +103.94% | Reiterates | 17 days ago |
Evaxion AEVAX | 14 | Buy | $16.00 | +185.71% | Reiterates | 17 days ago |
Actuate Therapeutics IncACTU | 3 | Buy | $20.00 | +211.53% | Reiterates | a month ago |
Dianthus Therapeutics IncDNTH | 7 | Buy | $40.00 | +20.48% | Reiterates | 2 months ago |
Personalis IncPSNL | 17 | Buy | $8.50 | -2.63% | Reiterates | 2 months ago |
Collplant Biotechnologies LtdCLGN | 10 | Buy | $11.00 | +395.50% | Reiterates | 3 months ago |
Precigen IncPGEN | 13 | Buy | $8.50 | +119.07% | Reiterates | 3 months ago |
Pyxis Oncology IncPYXS | 10 | Buy | $5.00 | +28.21% | Reiterates | 3 months ago |
Aethlon Medical IncAEMD | 2 | Hold | $15.00 | +231.86% | Reiterates | 3 months ago |
X4 Pharmaceuticals IncXFOR | 17 | Buy | $3.50 | -11.84% | Maintains | 3 months ago |
Humacyte IncHUMA | 2 | Buy | $3.00 | +105.48% | Maintains | 3 months ago |
Mirum Pharmaceuticals IncMIRM | 2 | Buy | $80.00 | +12.72% | Maintains | 3 months ago |
Nuvalent IncNUVL | 4 | Buy | $130.00 | +42.83% | Maintains | 4 months ago |
Ocugen IncOCGN | 20 | Buy | $7.00 | +389.51% | Reiterates | 4 months ago |
Elevation Oncology IncELEV | 9 | Hold | $0.36 | -1.37% | Downgrades | 5 months ago |
Eton Pharmaceuticals IncETON | 8 | Buy | $35.00 | +89.70% | Maintains | 5 months ago |
Mediwound LtdMDWD | 18 | Buy | $31.00 | +73.18% | Maintains | 5 months ago |
Renovorx IncRNXT | 3 | Buy | $3.00 | +194.12% | Reiterates | 6 months ago |
Alx Oncology Holdings IncALXO | 15 | Buy | $2.00 | +36.99% | Maintains | 6 months ago |
Ekso Bionics Holdings IncEKSO | 15 | Buy | $60.00 | +1,069.59% | Maintains | 6 months ago |
Mindwalk Holdings CorpHYFT | 11 | Buy | $5.00 | +184.09% | Reiterates | 7 months ago |
Spectral Ai IncMDAI | 4 | Buy | $3.50 | +77.66% | Reiterates | 7 months ago |
Edap Tms SaEDAP | 12 | Buy | $19.00 | +835.96% | Reiterates | 7 months ago |
Absci CorpABSI | 14 | Buy | $7.00 | +77.66% | Reiterates | 8 months ago |
In8bio IncINAB | 15 | Buy | $180.00 | +10,809.09% | Maintains | 8 months ago |
Electrocore IncECOR | 13 | Buy | $25.00 | +405.05% | Reiterates | 8 months ago |
Lifeward LtdLFWD | 16 | Buy | $13.00 | +2,250.81% | Reiterates | 8 months ago |
Iteos Therapeutics IncITOS | 11 | Buy | $46.00 | +353.20% | Reiterates | 8 months ago |
Janux Therapeutics IncJANX | 12 | Buy | $70.00 | +159.16% | Reiterates | 8 months ago |
Vericel CorpVCEL | 15 | Buy | $60.00 | +65.52% | Reiterates | 8 months ago |
Bicycle Therapeutics PLCBCYC | 16 | Buy | $33.00 | +380.35% | Reiterates | 8 months ago |
Leap Therapeutics IncLPTX | 13 | Buy | $5.50 | +1,218.94% | Reiterates | 10 months ago |
Quantum Si IncQSI | 6 | Buy | $5.50 | +198.91% | Reiterates | 10 months ago |
Affimed NvAFMDQ | 12 | Buy | $10.00 | +5,424.86% | Reiterates | a year ago |
Intensity Therapeutics IncINTS | 2 | Buy | $5.00 | +834.58% | Reiterates | a year ago |
Cyclo Therapeutics IncCYTH | 4 | Hold | $0.95 | N/A | Downgrades | a year ago |
Predictive Oncology IncPOAI | 1 | Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Asensus Surgical IncASXC | 11 | Hold | $0.35 | N/A | Reiterates | a year ago |
Mimedx Group IncMDXG | 8 | Buy | $11.00 | N/A | Reiterates | 2 years ago |
Calcimedica IncCALC | 1 | Buy | $20.00 | N/A | Reiterates | 2 years ago |
Avinger IncAVGR | 5 | Buy | $5.00 | N/A | Reiterates | 2 years ago |
Harpoon Therapeutics IncHARP | 8 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Solid Biosciences IncSLDB | 1 | Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Immunogen IncIMGN | 10 | Hold | $31.26 | N/A | Downgrades | 2 years ago |
Medicenna Therapeutics CorpMDNAF | 9 | Buy | $2.50 | N/A | Reiterates | 2 years ago |
Surface Oncology IncSURF | 6 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Alaunos Therapeutics IncTCRT | 3 | Buy | $225.00 | N/A | Upgrades | 2 years ago |
Surgalign Holdings IncSRGAQ | 3 | Buy | $3.50 | N/A | Reiterates | 2 years ago |
Codexis IncCDXS | 9 | Buy | $9.00 | N/A | Maintains | 3 years ago |
Lava Therapeutics NvLVTX | 1 | Buy | $9.00 | N/A | Reiterates | 3 years ago |
Celularity IncCELU | 2 | Buy | $25.00 | N/A | Maintains | 3 years ago |
Poseida Therapeutics IncPSTX | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Adagene IncADAG | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 3 years ago |
Oncorus IncONCR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cellectar Biosciences IncCLRB | 1 | Buy | $120.00 | N/A | Maintains | 3 years ago |
Aveo Pharmaceuticals IncAVEO | 4 | Hold | $15.00 | N/A | Downgrades | 3 years ago |
Calithera Biosciences IncCALA | 2 | Buy | $8.00 | N/A | Upgrades | 3 years ago |
Cervomed IncCRVO | 3 | Buy | $9.50 | N/A | Upgrades | 3 years ago |
Bioatla IncBCAB | 2 | Buy | $20.00 | N/A | Maintains | 3 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $11.00 | N/A | Maintains | 3 years ago |
Notable Labs LtdNTBLQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Pulse Biosciences IncPLSE | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Hookipa Pharma IncHOOK | 5 | Buy | $80.00 | N/A | Maintains | 4 years ago |
Trillium Therapeutics IncTRIL1 | 3 | Hold | $18.50 | N/A | Downgrades | 4 years ago |
Carisma Therapeutics IncCARM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $6.00 | N/A | Maintains | 4 years ago |
Kindred Biosciences IncKIN | 3 | Hold | $9.25 | N/A | Downgrades | 4 years ago |
Perspective Therapeutics IncCATX | 2 | Buy | $2.10 | N/A | Maintains | 5 years ago |
Inmune Bio IncINMB | 2 | Buy | $20.00 | N/A | Maintains | 5 years ago |
Intelgenx Technologies CorpIGXT | 1 | Buy | $0.50 | N/A | Reiterates | 6 years ago |
Casi Pharmaceuticals IncCASI | 1 | Buy | $35.00 | N/A | Maintains | 6 years ago |
Verastem IncVSTM | 1 | Buy | $33.00 | N/A | Maintains | 6 years ago |
Alphatec Holdings IncATEC | 2 | Buy | $9.50 | N/A | Reiterates | 6 years ago |
Redhill Biopharma LtdRDHL | 1 | Buy | $14,000.00 | N/A | Reiterates | 6 years ago |
Forty Seven IncFTSV | 1 | Hold | $95.50 | N/A | Downgrades | 6 years ago |
Correvio Pharma CorpCORV | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Ayala Pharmaceuticals IncADXS | 2 | Buy | $7,200.00 | N/A | Maintains | 8 years ago |
Aratana Therapeutics IncPETX | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 8 years ago |
Aceragen IncACGN | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 8 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Buy | $14.00 | N/A | Assumes | 8 years ago |
Seaspine Holdings CorpSPNE | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.